Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Oral Premalignant Lesions
NCT00014404Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2000
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in oral premalignant lesion (OPMD), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2000; status: completed.
02
Drugs
celecoxib
03
Conditions
oral premalignant lesion (OPMD)
Beyond the preview
Go deeper on NCT00014404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014404.